Amiselimod (MT-1303), a novel sphingosine 1-phosphate receptor-1 functional antagonist, inhibits progress of chronic colitis induced by transfer of CD4+CD45RBhigh T cells.

by Kyoko Shimano, Yasuhiro Maeda, Hirotoshi Kataoka, Mikako Murase, Sachiko Mochizuki, Hiroyuki Utsumi, Koichi Oshita, Kunio Sugahara
Published 2019-01-01